comparemela.com

Latest Breaking News On - Michael xue - Page 2 : comparemela.com

Epigenic secures funds to advance gene editing therapy

Epigenic Therapeutics has secured $20m in Series Angel and Pre-A funding to proceed with next-generation gene editing therapy.

Michael xueBob zhangTrinity innovation fundKingray capitalTigeryeah capitalMorningside venture capitalSeries pre aFountainbridge capitalVenture capitalEpigenic therapeutics

Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesHong kongMichael xueBob zhangEpigenic therapeutic technology platformPrnewswire epigenic therapeutics co ltdTrinity innovation fundSeries angelMorningside venture capitalKingray capitalFountainbridge capitalEpigenic therapeuticsManaging directorMorningside ventureEpigenic therapeuticChan family

Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy - Press Release

SHANGHAI, Aug. 6, 2022 /PRNewswire/ Epigenic Therapeutics Co., Ltd., a frontier biotechnology company dedicated to developing next generation gene

United statesHong kongMichael xueBob zhangEpigenic therapeutic technology platformEpigenic therapeutics co ltdTrinity innovation fundSeries angelMorningside venture capitalKingray capitalFountainbridge capitalEpigenic therapeuticsManaging directorMorningside ventureEpigenic therapeuticChan family

Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy

/PRNewswire/ Epigenic Therapeutics Co., Ltd., a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing.

United statesHong kongMichael xueBob zhangEpigenic therapeutic technology platformPrnewswire epigenic therapeutics co ltdTrinity innovation fundSeries angelMorningside venture capitalKingray capitalFountainbridge capitalEpigenic therapeuticsManaging directorMorningside ventureEpigenic therapeuticChan family

Huawei Offers Its Technology to NGOs - Bio Market Insights

Huawei announces it has offered its technology to non-governmental organizations with around 14 research projects related to environmental conservation in 10 countries.

Costa ricaChrissy durkinHuawei latin americaMichael xueMarcelo pinoInternational expansion for the rainforest connectionPublic affairs at huawei latin americaLatin americaRainforest connectionInternational expansionVice presidentPublic affairs

vimarsana © 2020. All Rights Reserved.